102 results on '"Khetsuriani N"'
Search Results
2. High degree of genetic diversity of non-polio enteroviruses identified in Georgia by environmental and clinical surveillance, 2002–2005
- Author
-
Khetsuriani, N., Kutateladze, T., Zangaladze, E., Shutkova, T., Peñaranda, S., Nix, W. A., Pallansch, M. A., and Oberste, M. S.
- Published
- 2010
- Full Text
- View/download PDF
3. Trends in encephalitis-associated deaths in the United States
- Author
-
KHETSURIANI, N., HOLMAN, R. C., LAMONTE-FOWLKES, A. C., SELIK, R. M., and ANDERSON, L. J.
- Published
- 2007
4. Measles and rubella seroprevalence among adults in Georgia in 2015: helping guide the elimination efforts
- Author
-
Khetsuriani, N., primary, Chitadze, N., additional, Russell, S., additional, and Ben Mamou, M., additional
- Published
- 2019
- Full Text
- View/download PDF
5. ISAAC STUDY IN THE REPUBLIC OF GEORGIA: DESCRIPTIVE DATA : P 410
- Author
-
Gamkrelidze, A., Khetsuriani, N., Gotua, M., and Gunia, N.
- Published
- 1996
6. ISAAC Study in the Republic of Georgia: Childhood Asthma
- Author
-
Gamkrelidze, A., Khetsuriani, N., Gotua, M., and Gunia, N.
- Published
- 1996
7. INFLUENCE OF POSITIVE FAMILY HISTORY OF ATOPY ON THE DEVELOPMENT OF ASTHMA IN CHILDREN
- Author
-
Gotua, M., Khetsuriani, N, Gunia, N, and Gamkrelidze, A
- Published
- 1996
8. Progress toward measles elimination--European region, 2005-2008
- Author
-
Martin, R., Deshevoi, S., Jankovic, D., Goel, A., Mercer, D., Laurent, E., Dabbagh, A., Strebel, P., Khetsuriani, N., Wassilak, S., and Uzicanin, A.
- Subjects
Measles -- Prevention ,Measles vaccine -- Dosage and administration ,Diseases -- Reporting - Abstract
In 2002, the World Health Organization (WHO) Regional Committee for the European Region (EUR) * revised earlier targets to eliminate indigenous measles and achieve rubella control (1) by resolving to [...]
- Published
- 2009
9. Balamuthia amebic encephalitis--California, 1999-2007
- Author
-
Glaser, C., Schuster, F., Yagi, S., Gavali, S., Bollen, A., Glastonbury, C., Raghavan, R., Michelson, D., Blomquist, I., Scharnhorst, D., Kuriyama, S., Reed, S., Ginsberg, M., Visvesvara, G., Wilkins, P., Anderson, L., Khetsuriani, N., and Fowlkes, A.L.
- Subjects
Encephalitis -- Causes of ,Encephalitis -- Case studies ,Amoeba -- Health aspects - Abstract
Balamuthia mandrillaris is a free-living ameba that causes encephalitis in humans (both immunocompetent and immunocompromised), horses, dogs, sheep, and nonhuman primates. The ameba is present in soil and likely is [...]
- Published
- 2008
10. Increased detections and severe neonatal disease associated with Coxsackievirus B1 infection--United States, 2007
- Author
-
Mascola, L., Terashita, D., Salzman, M.B., Schnurr, D., Yagi, S., Padilla, T., Verma, N., Zheng, X., Shulman, S.T., Harris, M.U., Gibson, R., Funk, E., Schmidt, T., Robinson, C., Burns, J.P., Khetsuriani, N., Oberste, S., Pallansch, M., Fowlkes, A., Wikswo, M., and Sircar, K.
- Subjects
Enteroviruses -- Case studies ,Enteroviruses -- Statistics ,Infants (Newborn) -- Diseases ,Infants (Newborn) -- Case studies ,Infants (Newborn) -- Statistics - Abstract
Enteroviruses generally cause mild disease; however, neonates are at higher risk for severe illness because of the immaturity of their immune systems. Neonatal systemic enterovirus disease, characterized by multiorgan involvement, [...]
- Published
- 2008
11. Enterovirus surveillance--United States, 2002-2004
- Author
-
Khetsuriani, N., LaMonte, A., Stockman, L., Oberste, S., Pallansch, M., Camp, B., and Malek, M.
- Subjects
Enterovirus diseases -- Diagnosis ,Enterovirus diseases -- Reports ,Enteroviruses -- Varieties - Abstract
Enteroviruses are common viruses associated with diverse clinical syndromes, ranging from minor febrile illness to severe, potentially fatal conditions (e.g., aseptic meningitis, encephalitis, paralysis, myocarditis, and neonatal enteroviral sepsis) (1,2). [...]
- Published
- 2006
12. Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data.
- Author
-
Tapiainen, T., Prevots, R., Izurieta, H.S., Abramson, J., Bilynsky, R., Bonhoeffer, J., Bonnet, M.C., Center, K., Galama, J.M.D., Gillard, P., Griot, M., Hartmann, K., Heininger, U., Hudson, M., Koller, A., Khetsuriani, N., Khuri-Bulos, N., Marcy, S.M., Matulionyte, R., Schondorf, I., Sejvar, J., Steele, R., Tapiainen, T., Prevots, R., Izurieta, H.S., Abramson, J., Bilynsky, R., Bonhoeffer, J., Bonnet, M.C., Center, K., Galama, J.M.D., Gillard, P., Griot, M., Hartmann, K., Heininger, U., Hudson, M., Koller, A., Khetsuriani, N., Khuri-Bulos, N., Marcy, S.M., Matulionyte, R., Schondorf, I., Sejvar, J., and Steele, R.
- Abstract
Contains fulltext : 52402.pdf (publisher's version ) (Closed access)
- Published
- 2007
13. What Will It Take to Achieve Measles Elimination in the World Health Organization European Region: Progress From 2003-2009 and Essential Accelerated Actions
- Author
-
Martin, R., primary, Wassilak, S., additional, Emiroglu, N., additional, Uzicanin, A., additional, Deshesvoi, S., additional, Jankovic, D., additional, Goel, A., additional, and Khetsuriani, N., additional
- Published
- 2011
- Full Text
- View/download PDF
14. Impact of unfounded vaccine safety concerns on the nationwide measles–rubella immunization campaign, Georgia, 2008
- Author
-
Khetsuriani, N., primary, Imnadze, P., additional, Baidoshvili, L., additional, Jabidze, L., additional, Tatishili, N., additional, Kurtsikashvili, G., additional, Lezhava, T., additional, Laurent, E., additional, and Martin, R., additional
- Published
- 2010
- Full Text
- View/download PDF
15. Ongoing measles and rubella transmission in Georgia, 2004-05: implications for the national and regional elimination efforts
- Author
-
Doshi, S., primary, Khetsuriani, N., additional, Zakhashvili, K., additional, Baidoshvili, L., additional, Imnadze, P., additional, and Uzicanin, A., additional
- Published
- 2008
- Full Text
- View/download PDF
16. Trends in encephalitis-associated deaths in the United States
- Author
-
KHETSURIANI, N., primary, HOLMAN, R. C., additional, LAMONTE-FOWLKES, A. C., additional, SELIK, R. M., additional, and ANDERSON, L. J., additional
- Published
- 2006
- Full Text
- View/download PDF
17. Prevalence of childhood asthma, rhinitis and eczema in Scandinavia and Eastern Europe.
- Author
-
Bjorksten, B, Dumitrascu, D, Foucard, T, Khetsuriani, N, Khaitov, R, Leja, M, Lis, G, Pekkanen, J, Priftanji, A, Riikjarv, MA, Bjorksten, B, Dumitrascu, D, Foucard, T, Khetsuriani, N, Khaitov, R, Leja, M, Lis, G, Pekkanen, J, Priftanji, A, and Riikjarv, MA
- Published
- 1998
18. Prevalence of childhood asthma, rhinitis and eczema in Scandinavia and Eastern Europe
- Author
-
Bjorksten, B, primary, Dumitrascu, D, additional, Foucard, T, additional, Khetsuriani, N, additional, Khaitov, R, additional, Leja, M, additional, Lis, G, additional, Pekkanen, J, additional, Priftanji, A, additional, and Riikjarv, MA, additional
- Published
- 1998
- Full Text
- View/download PDF
19. Enterovirus surveillance -- United States, 1970-2005.
- Author
-
Khetsuriani N, LaMonte-Fowlkes A, Oberste MS, and Pallansch MA
- Abstract
Problem: Enteroviruses are common human viruses associated with various clinical syndromes, from minor febrile illness to severe, potentially fatal conditions (e.g., aseptic meningitis, paralysis, myocarditis, and neonatal enteroviral sepsis). Multiple enterovirus serotypes exist. Individual serotypes have different temporal patterns of circulation and often are associated with different clinical manifestations. Changes in circulating serotypes might be accompanied by large-scale outbreaks.Reporting Period Covered: 1970--2005.Description of Surveillance System: The National Enterovirus Surveillance System (NESS) is a voluntary, passive surveillance system that has monitored trends in circulating enteroviruses since 1961. Enterovirus detections by serotype with specimen type, collection date, and demographic information are reported monthly by participating laboratories to CDC, which summarizes the data and disseminates the results. For this analysis, the available data set for 1970--1982 included only information on serotype and state for each report; complete records were available for 1983--2005.Results: During 1970--2005, a total of 52,812 enterovirus detections were reported to NESS (29,772 of them during 1983--2005). Laboratory participation and the numbers of reports declined throughout the 1990s, but they increased again after 2000. The 15 most commonly reported enteroviruses accounted for 83.5% of reports with known serotype, and the five most commonly reported serotypes (echoviruses [E] 9, 11, 30, and 6, and coxsackievirus B5) accounted for 48.1%. Predominant serotypes and ranking of individual enteroviruses changed over time. Long-term circulation patterns for individual serotypes varied but were consistent with epidemic (e.g., E9, E13, E30, and coxsackievirus B5) or endemic patterns (e.g., coxsackieviruses A9, B2, B4, and enterovirus 71). Children aged <1 year accounted for 44.2% of reports with known age. Male predominance was present among patients aged <20 years, but not among those aged >20 years (male/female ratio: 1.4 and 0.9, respectively). Enterovirus detections had prominent summer-fall seasonality, with June--October accounting for 77.9% of reports with known month of specimen collection. Cerebrospinal fluid was the most common specimen type, followed by respiratory and fecal specimens (49.8%, 26.9%, and 13.6%, respectively). Death was reported for 3.3% of detections with known outcome. Infections with coxsackievirus B4 (odds ratio [OR] = 3.3; 95% confidence interval [CI] = 1.7--6.0), and human parechovirus 1 (formerly E22) (OR = 3.7; CI = 1.7--7.6) were associated with higher risk for death, and infections with E9 were associated with lower risk for death (OR = 0.1; CI = 0--0.4) than infections with other enteroviruses.Interpretation: NESS data allowed identification and description of a core group of consistently circulating enteroviruses that probably determine the disease burden associated with enterovirus infections. These data also are helpful in guiding outbreak investigations and identifying targets for development of diagnostic assays and antivirals. Efforts to update the reporting system initiated in the early 2000s (i.e., simplification of reporting forms and transition to electronic reporting) resulted in a substantial increase in reporting compared with the late 1990s.Public Health Action: Efforts to increase laboratory participation in NESS should continue to allow for more complete and accurate surveillance for enteroviruses. Further improvement in the timeliness of feedback through the development of a NESS website to allow access to historic data and to the information on circulating serotypes can provide additional incentives to public health laboratories to participate in NESS. [ABSTRACT FROM AUTHOR]
- Published
- 2006
20. Tetanus surveillance -- United States, 1995-1997.
- Author
-
Bardenheier B, Prevots DR, Khetsuriani N, and Wharton M
- Abstract
Problem/Conditions: Despite widespread availability of a safe and effective vaccine against tetanus, 124 cases of the disease were reported during 1995-1997. Only 13% of patients reported having received a primary series of tetanus toxoid (TT) before disease onset. Of patients with known illness outcome, the case-fatality ratio was 11%. Reporting Period Covered: 1995-1997. Description of System: Physician-diagnosed cases of tetanus are reported by state and local health departments to CDC's National Notifiable Diseases Surveillance System. In addition, since 1965, supplemental clinical and epidemiologic information for cases has been provided to CDC's National Immunization Program. Results: From 1995 through 1997, a total of 124 cases of tetanus were reported from 33 states and the District of Columbia, accounting for an average annual incidence of 0.15 cases per 1,000,000 population. Sixty percent of patients were aged 20-59 years; 35% were aged >/=60 years; and 5% were aged <20 years, including one case of neonatal tetanus. For adults aged >/=60 years, the increased risk for tetanus was nearly sevenfold that for persons aged 5-19 years and twofold that for persons aged 20-59 years. The case-fatality ratio varied from 2.3% for persons aged 20-39 years to 16% for persons aged 40-59 years and to 18% for persons aged >/=60 years. Only 13% of patients reported having received a primary series of TT before disease onset. Previous vaccination status was directly related to severity of disease, with the case-fatality ratio ranging from 6% for patients who had received one to two doses to 15% for patients who were unvaccinated. No deaths occurred among the 16 patients who previously had received three or more doses. Tetanus occurred following an acute injury in 77% of patients, but only 41% sought medical care for their injury. All patients who sought care were eligible for TT as part of wound prophylaxis, but only 39% received it. Tetanus in injecting-drug users (IDUs) with no known acute injury comprised 11% of all cases, compared with 3.6% during 1991-1994. None of the IDU-associated tetanus cases occurred among persons who were known to have been vaccinated. Sixty-nine percent of IDU-associated tetanus cases were reported from California, and 77% of these cases occurred in heroin users. Interpretation: Tetanus remains a severe disease that primarily affects unvaccinated or inadequately vaccinated persons. Adults aged >/=60 years continue to be at highest risk for tetanus and for severe disease. However, the overall incidence of tetanus has decreased slightly since the late 1980s and early 1990s, from 0.20 to 0.15, a result primarily of a decreased incidence among persons aged >/=60 and <20 years. Actions Taken: Tetanus is preventable through both routine vaccination and appropriate wound management. In addition to decennial booster doses of diphtheria and tetanus toxoids during adult life, the Advisory Committee on Immunization Practices (ACIP) recommends vaccination visits for adolescents at age 11-12 years and for adults at age 50 years to enable health-care providers to review vaccination histories and administer any needed vaccine. Every contact with the health-care system, particularly among older adults and IDUs, should be used to review and update vaccination status as needed. [ABSTRACT FROM AUTHOR]
- Published
- 1998
21. Limited duration of vaccine poliovirus and other enterovirus excretion among human immunodeficiency virus infected children in Kenya
- Author
-
Tukei Peter, Oberste M, Fowlkes Ashley, Kew Olen, Pallansch Mark, Helfand Rita, Khetsuriani Nino, Muli Joseph, Makokha Ernest, and Gary Howard
- Subjects
Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background Immunodeficient persons with persistent vaccine-related poliovirus infection may serve as a potential reservoir for reintroduction of polioviruses after wild poliovirus eradication, posing a risk of their further circulation in inadequately immunized populations. Methods To estimate the potential for vaccine-related poliovirus persistence among HIV-infected persons, we studied poliovirus excretion following vaccination among children at an orphanage in Kenya. For 12 months after national immunization days, we collected serial stool specimens from orphanage residents aged Results Twenty-four children (15 HIV-infected, 9 HIV-uninfected) were enrolled, and 255 specimens (170 from HIV-infected, 85 from HIV-uninfected) were collected. All HIV-infected children had mildly or moderately symptomatic HIV-disease and moderate-to-severe immunosuppression. Fifteen participants shed vaccine-related polioviruses, and 22 shed NPEV at some point during the study period. Of 46 poliovirus-positive specimens, 31 were from HIV-infected, and 15 from HIV-uninfected children. No participant shed polioviruses for ≥ 6 months. Genomic sequencing of poliovirus isolates did not reveal any genetic evidence of long-term shedding. There was no long-term shedding of NPEV. Conclusion The results indicate that mildly to moderately symptomatic HIV-infected children retain the ability to clear enteroviruses, including vaccine-related poliovirus. Larger studies are needed to confirm and generalize these findings.
- Published
- 2009
- Full Text
- View/download PDF
22. Nationwide Hepatitis C Serosurvey and Progress Towards Hepatitis C Virus Elimination in the Country of Georgia, 2021.
- Author
-
Gamkrelidze A, Shadaker S, Tsereteli M, Alkhazashvili M, Chitadze N, Tskhomelidze I, Gvinjilia L, Khetsuriani N, Handanagic S, Averhoff F, Cloherty G, Chakhunashvili G, Drobeniuc J, Imnadze P, Zakhashvili K, and Armstrong PA
- Subjects
- Adult, Humans, Georgia epidemiology, Risk Factors, RNA, Prevalence, Hepacivirus genetics, Hepatitis C epidemiology, Hepatitis C prevention & control
- Abstract
Background: The country of Georgia initiated its hepatitis C virus (HCV) elimination program in 2015, at which point a serosurvey showed the adult prevalence of HCV antibody (anti-HCV) and HCV RNA to be 7.7% and 5.4%, respectively. This analysis reports hepatitis C results of a follow-up serosurvey conducted in 2021, and progress towards elimination., Methods: The serosurvey used a stratified, multistage cluster design with systematic sampling to include adults and children (aged 5-17 years) providing consent (or assent with parental consent). Blood samples were tested for anti-HCV and if positive, HCV RNA. Weighted proportions and 95% confidence intervals (CI) were compared with 2015 age-adjusted estimates., Results: Overall, 7237 adults and 1473 children were surveyed. Among adults, the prevalence of anti-HCV was 6.8% (95% CI, 5.9-7.7). The HCV RNA prevalence was 1.8% (95% CI, 1.3-2.4), representing a 67% reduction since 2015. HCV RNA prevalence decreased among those reporting risk factors of ever injecting drugs (51.1% to 17.8%), and ever receiving a blood transfusion (13.1% to 3.8%; both P < .001). No children tested positive for anti-HCV or HCV RNA., Conclusions: These results demonstrate substantial progress made in Georgia since 2015. These findings can inform strategies to meet HCV elimination targets., Competing Interests: Potential conflicts of interest. F. A. and G. C. are employed by and own stock in Abbott Diagnostics. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed., (Published by Oxford University Press on behalf of Infectious Diseases Society of America 2023.)
- Published
- 2023
- Full Text
- View/download PDF
23. Toward reaching hepatitis B goals: hepatitis B epidemiology and the impact of two decades of vaccination, Georgia, 2021.
- Author
-
Khetsuriani N, Gamkrelidze A, Shadaker S, Tsereteli M, Alkhazashvili M, Chitadze N, Tskhomelidze I, Gvinjilia L, Averhoff F, Cloherty G, An Q, Chakhunashvili G, Drobeniuc J, Imnadze P, Zakhashvili K, and Armstrong PA
- Subjects
- Adult, Female, Humans, Cross-Sectional Studies, Georgia, Hepatitis B Antibodies, Hepatitis B virus, Seroepidemiologic Studies, Vaccination, Male, Child, Preschool, Child, Adolescent, Middle Aged, Hepatitis B epidemiology, Hepatitis B prevention & control, Hepatitis B Surface Antigens, Hepatitis B Vaccines administration & dosage
- Abstract
BackgroundGeorgia has adopted the World Health Organization European Region's and global goals to eliminate viral hepatitis. A nationwide serosurvey among adults in 2015 showed 2.9% prevalence for hepatitis B virus (HBV) surface antigen (HBsAg) and 25.9% for antibodies against HBV core antigen (anti-HBc). HBV infection prevalence among children had previously not been assessed.AimWe aimed to assess HBV infection prevalence among children and update estimates for adults in Georgia.MethodsThis nationwide cross-sectional serosurvey conducted in 2021 among persons aged ≥ 5 years used multi-stage stratified cluster design. Participants aged 5-20 years were eligible for hepatitis B vaccination as infants. Blood samples were tested for anti-HBc and, if positive, for HBsAg. Weighted proportions and 95% confidence intervals (CI) were calculated for both markers.ResultsAmong 5-17 year-olds (n = 1,473), 0.03% (95% CI: 0-0.19) were HBsAg-positive and 0.7% (95% CI: 0.3-1.6) were anti-HBc-positive. Among adults (n = 7,237), 2.7% (95% CI: 2.3-3.4) were HBsAg-positive and 21.7% (95% CI: 20.4-23.2) anti-HBc-positive; HBsAg prevalence was lowest (0.2%; 95% CI: 0.0-1.5) among 18-23-year-olds and highest (8.6%; 95% CI: 6.1-12.1) among 35-39-year-olds.ConclusionsHepatitis B vaccination in Georgia had remarkable impact. In 2021, HBsAg prevalence among children was well below the 0.5% hepatitis B control target of the European Region and met the ≤ 0.1% HBsAg seroprevalence target for elimination of mother-to-child transmission of HBV. Chronic HBV infection remains a problem among adults born before vaccine introduction. Screening, treatment and preventive interventions among adults, and sustained high immunisation coverage among children, can help eliminate hepatitis B in Georgia by 2030.
- Published
- 2023
- Full Text
- View/download PDF
24. Progress Toward the Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Worldwide, 2016-2021.
- Author
-
Khetsuriani N, Lesi O, Desai S, Armstrong PA, and Tohme RA
- Subjects
- Female, Hepatitis B Surface Antigens, Hepatitis B Vaccines, Hepatitis B virus, Humans, Infant, Infant, Newborn, Infectious Disease Transmission, Vertical prevention & control, Prevalence, Hepatitis B epidemiology, Hepatitis B prevention & control, Hepatitis B, Chronic epidemiology, Hepatitis B, Chronic prevention & control
- Abstract
Mother-to-child transmission (MTCT) of hepatitis B virus (HBV) often results in chronic HBV infection, the leading cause of cirrhosis and liver cancer (1). If not vaccinated, nine in 10 children infected at birth will become chronically infected. Globally, an estimated 6.4 million (range = 4.4-10.8 million) children aged ≤5 years are living with chronic HBV infection (2). In 2016, the World Health Assembly endorsed the goal to eliminate viral hepatitis as a public health threat by 2030, including the elimination of MTCT of HBV (3). Elimination of MTCT of HBV can be validated by demonstrating ≤0.1% prevalence of HBV surface antigen (HBsAg) among children aged ≤5 years, as well as ≥90% coverage with hepatitis B birth dose (HepB-BD) and 3 doses of hepatitis B vaccine (HepB3) (4,5). This report describes global progress toward elimination of MTCT of HBV during 2016-2021. By December 2020, 190 (98%) of 194 World Health Organization (WHO) member states* had introduced universal infant vaccination with hepatitis B vaccine (HepB), and 110 (57%) countries provided HepB-BD to all newborns. During 2016-2020, global HepB3 coverage remained between 82% and 85%, whereas HepB-BD coverage increased from 37% to 43%. In 2020, among the 99 countries reporting both HepB3 and HepB-BD coverage, 41 (41%) achieved ≥90% coverage with both. By December 2021, serosurveys documented ≤0.1% HBsAg prevalence among children in 11 countries. Accelerating HepB-BD introduction, increasing HepB3 coverage, and monitoring programmatic and impact indicators are essential for elimination of MTCT of HBV., Competing Interests: All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
- Published
- 2022
- Full Text
- View/download PDF
25. Policy and practice of checking vaccination status at school in 2018, a global overview.
- Author
-
Sadigh K, Fox G, Khetsuriani N, Gao H, Shendale S, and Ward K
- Subjects
- Child, Humans, Policy, Schools, United States, World Health Organization, Immunization Programs, Vaccination
- Abstract
Background: Checking vaccination status at school is widely recommended as a strategy to strengthen routine childhood vaccination coverage. Documentation of approaches, challenges, strengths, and impact of this strategy in a variety of contexts is key to enhancing adoption and implementation. However, there is limited information about the prevalence of policies and the implementation of checking vaccination status at school globally., Methods: A one-time supplementary survey was circulated with the annual World Health Organization (WHO) and United Nations International Children's Emergency Fund (UNICEF) Joint Reporting Form in 2019 to all WHO member states and non-member state reporting entities. Additional publicly available country-level data, including primary school enrollment, home-based record (HBR) ownership, and World Bank income classification were linked to the supplementary survey responses, which were descriptively analyzed., Results: We received survey responses from 130 of the 194 (67%) WHO member states and 15 non-member state reporting entities. Almost half (46%) of the respondents reported having a law requiring proof of vaccination to enter at least one level of education, and 60% of the respondents reported having a law that requires checking vaccination status at school in 2018. Three-quarters of the respondents (77%) reported the practice of routinely checking vaccination status at school. Both laws and the practice of checking were more common in the WHO Region of the Americas and the WHO European Region, and in high- and upper-middle-income countries. Individual HBR was the document most frequently checked. Catch-up vaccination occurred most frequently at health centers. Evaluation of checking vaccination status at school to determine what has worked and its effect was infrequently reported., Conclusion: Despite widespread implementation of checking vaccination status at school in 2018, documentation of the experiences in planning and implementing this strategy, and its effects remains sparse, particularly in low- and middle-income countries., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022. Published by Elsevier Ltd.)
- Published
- 2022
- Full Text
- View/download PDF
26. Diphtheria and tetanus seroepidemiology among children in Ukraine, 2017.
- Author
-
Khetsuriani N, Zaika O, Slobodianyk L, Scobie HM, Cooley G, Dimitrova SD, Stewart B, Geleishvili M, Allahverdiyeva V, O'Connor P, and Huseynov S
- Subjects
- Adolescent, Antibodies, Bacterial, Child, Diphtheria-Tetanus Vaccine, Humans, Seroepidemiologic Studies, Ukraine epidemiology, Diphtheria epidemiology, Diphtheria prevention & control, Tetanus epidemiology, Tetanus prevention & control
- Abstract
Background: The drastic decline of Ukraine's immunization coverage since 2009 led to concerns about potential resurgence diphtheria and tetanus, along with other vaccine-preventable diseases., Methods: To assess population immunity against diphtheria and tetanus, we tested specimens from the serosurvey conducted in 2017 among children born in 2006-2015, the birth cohorts targeted by the nationwide outbreak response immunization following a circulating vaccine-derived poliovirus type 1 outbreak in Zakarpattya province in 2015. We surveyed four regions of Ukraine, using cluster sampling in Zakarpattya, Sumy, and Odessa provinces and simple random sampling in Kyiv City. We tested serum specimens for IgG antibodies against diphtheria and tetanus, using microbead assays (MBA). We estimated seroprevalence and calculated 95% confidence intervals. We also obtained information on the immunization status of surveyed children., Results: Seroprevalence of ≥0.1 IU/mL diphtheria antibodies was <80% in all survey sites (50.0%-79.2%). Seroprevalence of ≥0.1 IU/mL tetanus antibodies was ≥80% in Sumy, Kyiv City, and Odessa (80.2%-89.1%) and 61.6% in Zakarpattya. Across the sites, the proportion of children vaccinated age-appropriately with diphtheria-tetanus-containing vaccines (DTCV) was 28.5%-57.4% among children born in 2006-2010 and 34.1%-54.3% among children born in 2011-2015. The proportion of recipients of <3 DTCV doses increased from 7.1%-16.7% among children born in 2006-2010 to 19.8%-38.6% among children born in 2011-2015, as did the proportion of recipients of zero DTCV doses (2.6%-8.8% versus 8.0%-14.0%, respectively)., Conclusions: Protection against diphtheria among children born in 2006-2015 was suboptimal (<80%), particularly in Zakarpattya. Protection against tetanus was adequate (≥80%) except in Zakarpattya. Diphtheria-tetanus immunization status was suboptimal across all sites. Catch-up vaccination of unvaccinated/under-vaccinated children and other efforts to increase immunization coverage would close these immunity gaps and prevent the resurgence of diphtheria and tetanus in Ukraine, particularly in Zakarpattya., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022. Published by Elsevier Ltd.)
- Published
- 2022
- Full Text
- View/download PDF
27. Progress Toward Hepatitis B Control - World Health Organization European Region, 2016-2019.
- Author
-
Khetsuriani N, Mosina L, Van Damme P, Mozalevskis A, Datta S, and Tohme RA
- Subjects
- Adolescent, Adult, Aged, Child, Child, Preschool, Europe epidemiology, Female, Hepatitis B Surface Antigens blood, Hepatitis B Vaccines administration & dosage, Humans, Immunization Schedule, Infant, Infant, Newborn, Male, Middle Aged, Post-Exposure Prophylaxis, Pregnancy, Prenatal Diagnosis statistics & numerical data, Seroepidemiologic Studies, World Health Organization, Young Adult, Hepatitis B epidemiology, Hepatitis B prevention & control
- Abstract
In 2019, an estimated 14 million persons in the World Health Organization (WHO) European Region* (EUR) were chronically infected with hepatitis B virus (HBV), and approximately 43,000 of these persons died from complications of chronic HBV infection (1). In 2016, the WHO Regional Office for Europe set hepatitis B control program targets for 2020, including 1) ≥90% coverage with 3 doses of hepatitis B vaccine (HepB3), 2) ≥90% coverage with interventions to prevent mother-to-child transmission (MTCT) of HBV,
† and 3) ≤0.5% prevalence of HBV surface antigen (HBsAg)§ in age groups eligible for vaccination with hepatitis B vaccine (HepB) (2-4). This report describes the progress made toward hepatitis B control in EUR during 2016-2019. By December 2019, 50 (94%) of 53 countries in EUR provided routine vaccination with HepB to all infants or children aged 1-12 years (universal HepB), including 23 (43%) countries that offered hepatitis B birth dose (HepB-BD) to all newborns. In addition, 35 (73%) of the 48 countries with universal infant HepB vaccination reached ≥90% HepB3 coverage annually during 2017-2019, and 19 (83%) of the 23 countries with universal birth dose administration achieved ≥90% timely HepB-BD coverage¶ annually during that period. Antenatal hepatitis B screening coverage was ≥90% in 17 (57%) of 30 countries that selectively provided HepB-BD to infants born to mothers with positive HBsAg test results. In January 2020, Italy and the Netherlands became the first counties in EUR to be validated to have achieved the regional hepatitis B control targets. Countries can accelerate progress toward hepatitis B control by improving coverage with HepB and interventions to prevent MTCT and documenting achievement of the HBsAg seroprevalence target through representative serosurveys or, in low-endemicity countries, antenatal screening., Competing Interests: All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.- Published
- 2021
- Full Text
- View/download PDF
28. Validation of a diphtheria toxoid multiplex bead assay for serosurveys.
- Author
-
Scobie HM, Khetsuriani N, Efstratiou A, and Priest JW
- Subjects
- Animals, Chlorocebus aethiops, Neutralization Tests methods, Reproducibility of Results, Sensitivity and Specificity, Serologic Tests standards, Vero Cells, Antibodies, Bacterial blood, Diphtheria Toxoid, Immunoglobulin G blood, Serologic Tests methods
- Abstract
We validated a multiplex bead assay for diphtheria toxoid IgG antibodies against the Vero cell toxin neutralization test using 1300 specimens (correlation = 0.88). At the ≥0.01 IU/mL cutoff for minimal seroprotection, sensitivity was 95% and specificity was 83%. Agreement for three categories (<0.01, 0.01-<0.1, ≥0.1 IU/mL) was 81% (kappa = 0.71)., (Published by Elsevier Inc.)
- Published
- 2021
- Full Text
- View/download PDF
29. Seroprevalence of hepatitis B virus infection markers among children in Ukraine, 2017.
- Author
-
Khetsuriani N, Zaika O, Chitadze N, Slobodianyk L, Allahverdiyeva V, O'Connor P, and Huseynov S
- Subjects
- Child, Hepatitis B Antibodies, Hepatitis B Surface Antigens, Hepatitis B virus, Humans, Prevalence, Seroepidemiologic Studies, Ukraine, Vaccination, Hepatitis B epidemiology, Hepatitis B Vaccines
- Abstract
Background: Before hepatitis B vaccine (HepB) introduction, level of endemicity of hepatitis B virus (HBV) in Ukraine was estimated as intermediate but the prevalence of HBV infection markers has not been measured in population-based serosurveys. Coverage with 3 doses of HepB, introduced in 2002, was 92%-98% during 2004-2007 but declined to 21%-48% during 2010-2016. To obtain data on HBV prevalence among children born after HepB introduction, we tested specimens from a serosurvey conducted in Ukraine in 2017, following circulating vaccine-derived poliovirus outbreak in 2015, among birth cohorts eligible for polio immunization response., Methods: The serosurvey was conducted in Zakarpattya, Sumy, and Odessa provinces, and Kyiv City, targeting 2006-2015 birth cohorts. One-stage cluster sampling in the provinces and stratified simple random sampling in Kyiv were used for participant selection. All participants were tested for antibodies against HBV core antigen (anti-HBc). Anti-HBc-positive children were tested for HBV surface antigen (HBsAg). We also obtained information on HepB vaccination status for all children., Results: Of 4,596 children tested, 81 (1.8%) were anti-HBc-positive and eight (0.2%) were HBsAg-positive. HBsAg prevalence was 0.7% (95% confidence interval, 0.3%-1.4%) in Zakarpattya, 0.1% (0.0%-0.4%) in Sumy, 0% (0.0%-03%) in Odessa, and 0.1% (0.0%-0.8%) in Kyiv. Across survey sites, the proportion of recipients of ≥ 3 HepB doses was 53%-80% in the 2006-2009 cohort and 28%-59% in the 2010-2015 cohort., Conclusion: HBV prevalence among children in surveyed regions of Ukraine in 2017 was low, including in Zakarpattya-the only site above the 0.5% European Regional target for HBsAg seroprevalence. However, HepB vaccination was suboptimal, particularly among children born after 2009, resulting in large numbers of unvaccinated or incompletely vaccinated children at risk of future HBV infection. HepB coverage should be increased to further reduce HBV transmission among children in Ukraine and achieve regional and global hepatitis B control/elimination targets., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Published by Elsevier Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
30. Challenges to Achieving Measles Elimination, Georgia, 2013-2018.
- Author
-
Khetsuriani N, Sanadze K, Chlikadze R, Chitadze N, Dolakidze T, Komakhidze T, Jabidze L, Huseynov S, Ben Mamou M, Muller C, Zakhashvili K, and Hübschen JM
- Subjects
- Adolescent, Adult, Child, Child, Preschool, Disease Outbreaks prevention & control, Female, Georgia (Republic) epidemiology, Humans, Immunization Programs, Infant, Infant, Newborn, Male, Middle Aged, Vaccination, Vaccination Coverage, Young Adult, Disease Eradication, Measles epidemiology, Measles prevention & control, Measles Vaccine administration & dosage
- Abstract
Controlling measles outbreaks in the country of Georgia and throughout Europe is crucial for achieving the measles elimination goal for the World Health Organization's European Region. However, large-scale measles outbreaks occurred in Georgia during 2013-2015 and 2017-2018. The epidemiology of these outbreaks indicates widespread circulation and genetic diversity of measles viruses and reveals persistent gaps in population immunity across a wide age range that have not been sufficiently addressed thus far. Historic problems and recent challenges with the immunization program contributed to outbreaks. Addressing population susceptibility across all age groups is needed urgently. However, conducting large-scale mass immunization campaigns under the current health system is not feasible, so more selective response strategies are being implemented. Lessons from the measles outbreaks in Georgia could be useful for other countries that have immunization programs facing challenges related to health-system transitions and the presence of age cohorts with historically low immunization coverage.
- Published
- 2020
- Full Text
- View/download PDF
31. Assessment of Economic Burden of Concurrent Measles and Rubella Outbreaks, Romania, 2011-2012.
- Author
-
Njau J, Janta D, Stanescu A, Pallas SS, Pistol A, Khetsuriani N, Reef S, Ciurea D, Butu C, Wallace AS, and Zimmerman L
- Subjects
- Adolescent, Child, Child, Preschool, Costs and Cost Analysis, Female, Health Care Costs, History, 21st Century, Humans, Infant, Infant, Newborn, Male, Measles history, Measles virology, Public Health Surveillance, Romania epidemiology, Rubella history, Rubella virology, Rubella Syndrome, Congenital epidemiology, Rubella Syndrome, Congenital virology, Socioeconomic Factors, Coinfection, Cost of Illness, Disease Outbreaks, Measles epidemiology, Rubella epidemiology
- Abstract
We estimated the economic impact of concurrent measles and rubella outbreaks in Romania during 2011-2012. We collected costs from surveys of 428 case-patients and caretakers, government records, and health staff interviews. We then estimated financial and opportunity costs. During the study period, 12,427 measles cases and 24,627 rubella cases were recorded; 27 infants had congenital rubella syndrome (CRS). The cost of the outbreaks was US $9.9 million. Cost per case was US $439 for measles, US $132 for rubella, and US $44,051 for CRS. Up to 36% of households needed to borrow money to pay for illness treatment. Approximately 17% of patients continued to work while ill to pay their treatment expenses. Our key study findings were that households incurred a high economic burden compared with their incomes, the health sector bore most costs, and CRS costs were substantial and relevant to include in rubella outbreak cost studies.
- Published
- 2019
- Full Text
- View/download PDF
32. Responding to a cVDPV1 outbreak in Ukraine: Implications, challenges and opportunities.
- Author
-
Khetsuriani N, Perehinets I, Nitzan D, Popovic D, Moran T, Allahverdiyeva V, Huseynov S, Gavrilin E, Slobodianyk L, Izhyk O, Sukhodolska A, Hegazi S, Bulavinova K, Platov S, and O'Connor P
- Subjects
- Adolescent, Child, Disease Eradication, Female, Humans, Infant, Male, Poliomyelitis etiology, Poliovirus genetics, Poliovirus physiology, Ukraine epidemiology, Vaccination, Vaccination Refusal, Disease Outbreaks statistics & numerical data, Poliomyelitis epidemiology, Poliomyelitis virology, Poliovirus isolation & purification, Poliovirus Vaccine, Oral administration & dosage, Poliovirus Vaccines administration & dosage
- Abstract
Background: The European Region, certified polio-free in 2002, remains at risk of wild poliovirus reintroduction and emergence of circulating vaccine-derived polioviruses (cVDPV) until global polio eradication is achieved, as demonstrated by the cVDPV1 outbreak in Ukraine in 2015., Methods: We reviewed epidemiologic, clinical and virology data on cVDPV cases, surveillance and immunization coverage data, and reports of outbreak-related surveys, country missions, and expert group meetings., Results: In Ukraine, 3-dose polio vaccine coverage declined from 91% in 2008 to 15% by mid-2015. In summer, 2015, two unrelated children from Zakarpattya province were paralyzed by a highly divergent cVDPV1. The isolates were 20 and 26 nucleotide divergent from prototype Sabin strain (with 18 identical mutations) consistent with their common origin and ∼2-year evolution. Outbreak response recommendations developed with international partner support included conducting three nationwide supplementary immunization activities (SIAs) with tOPV, strengthening surveillance and implementing communication interventions. SIAs were conducted during October 2015-February 2016 (officially reported coverage, round 1-64.4%, round 2-71.7%, and round 3-80.7%). Substantial challenges to outbreak response included lack of high-level support, resistance to OPV use, low perceived risk of polio, widespread vaccine hesitancy, anti-vaccine media environment, economic crisis and military conflict. Communication activities improved caregiver awareness of polio and confidence in vaccination. Surveillance was enhanced but did not consistently meet applicable performance standards. Post-outbreak assessments concluded that cVDPV1 transmission in Ukraine has likely stopped following the response, but significant gaps in population immunity and surveillance remained., Conclusions: Chronic under-vaccination in Ukraine resulted in the accumulation of children susceptible to polioviruses and created favorable conditions for VDPV1 emergence and circulation, leading to the outbreak. Until programmatic gaps in immunization and surveillance are addressed, Ukraine will remain at high-risk for VDPV emergence and circulation, as well as at risk for other vaccine-preventable diseases., (Published by Elsevier Ltd.)
- Published
- 2017
- Full Text
- View/download PDF
33. Substantial decline in hepatitis B virus infections following vaccine introduction in Tajikistan.
- Author
-
Khetsuriani N, Tishkova F, Jabirov S, Wannemuehler K, Kamili S, Pirova Z, Mosina L, Gavrilin E, Ursu P, and Drobeniuc J
- Subjects
- Adolescent, Adult, Child, Child, Preschool, Female, Hepatitis B Surface Antigens immunology, Humans, Infant, Male, Seroepidemiologic Studies, Tajikistan epidemiology, Young Adult, Hepatitis B epidemiology, Hepatitis B prevention & control, Hepatitis B Antibodies blood, Hepatitis B Surface Antigens blood, Hepatitis B Vaccines administration & dosage, Hepatitis B Vaccines immunology
- Abstract
Background: Tajikistan, considered highly endemic area for hepatitis B virus (HBV) in a pre-vaccine era, introduced hepatitis B vaccine in 2002 and reported ≥80% coverage with three doses of hepatitis B vaccine (HepB3) since 2004. However, the impact of vaccine introduction has not been assessed., Methods: We tested residual serum specimens from a 2010 national serosurvey for vaccine-preventable diseases in Tajikistan and assessed the prevalence of HBV infection across groups defined based on the birth cohorts' routine infant hepatitis B vaccination program implementation and HepB3 coverage achieved (≥80% versus <80%). Serosurvey participants were selected through stratified multi-stage cluster sampling among residents of all regions of Tajikistan aged 1-24 years. All specimens were tested for antibodies against HBV core antigen (anti-HBc) and those found positive were tested for HBV surface antigen (HBsAg). Seroprevalence and 95% confidence intervals were calculated and compared across subgroups using Satterthwaite-adjusted chi-square tests, accounting for the survey design and sampling weights., Results: A total of 2188 samples were tested. Prevalence of HBV infection markers was lowest among cohorts with ≥80% HepB3 coverage (ages, 1-6 years): 2.1% (95% confidence interval, 1.1-4.3%) for anti-HBc, 0.4% (0.1-1.3%) for HBsAg, followed by 7.2% (4.1-12.4%) for anti-HBc and 2.1% (0.7-6.1%) for HBsAg among cohorts with <80% HepB3 coverage (ages, 7-8 years), by 12.0% (8.7-16.3%) for anti-HBc and 3.5% (2.2-5.6%) for HBsAg among children's cohorts not targeted for vaccination (ages, 9-14 years), and 28.9% (24.5-33.8%) for anti-HBc and 6.8% (4.5-10.1%) for HBsAg among unvaccinated adult cohorts (ages, 15-24 years). Differences across groups were significant (p<0.001, chi-square) for both markers., Conclusions: The present study demonstrates substantial impact of hepatitis B vaccine introduction on reducing HBV infections in Tajikistan. To achieve further progress in hepatitis B control, Tajikistan should maintain high routine coverage with hepatitis B vaccine, including birth dose., (Published by Elsevier Ltd.)
- Published
- 2015
- Full Text
- View/download PDF
34. Infectious causes of encephalitis and meningoencephalitis in Thailand, 2003-2005.
- Author
-
Olsen SJ, Campbell AP, Supawat K, Liamsuwan S, Chotpitayasunondh T, Laptikulthum S, Viriyavejakul A, Tantirittisak T, Tunlayadechanont S, Visudtibhan A, Vasiknanonte P, Janjindamai S, Boonluksiri P, Rajborirug K, Watanaveeradej V, Khetsuriani N, and Dowell SF
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Encephalitis history, Female, Glasgow Coma Scale, History, 21st Century, Hospitalization, Humans, Infant, Infant, Newborn, Male, Meningoencephalitis history, Middle Aged, Mortality, Seasons, Thailand epidemiology, Young Adult, Encephalitis epidemiology, Encephalitis etiology, Meningoencephalitis epidemiology
- Abstract
Acute encephalitis is a severe neurologic syndrome. Determining etiology from among ≈100 possible agents is difficult. To identify infectious etiologies of encephalitis in Thailand, we conducted surveillance in 7 hospitals during July 2003-August 2005 and selected patients with acute onset of brain dysfunction with fever or hypothermia and with abnormalities seen on neuroimages or electroencephalograms or with cerebrospinal fluid pleocytosis. Blood and cerebrospinal fluid were tested for >30 pathogens. Among 149 case-patients, median age was 12 (range 0-83) years, 84 (56%) were male, and 15 (10%) died. Etiology was confirmed or probable for 54 (36%) and possible or unknown for 95 (64%). Among confirmed or probable etiologies, the leading pathogens were Japanese encephalitis virus, enteroviruses, and Orientia tsutsugamushi. No samples were positive for chikungunya, Nipah, or West Nile viruses; Bartonella henselae; or malaria parasites. Although a broad range of infectious agents was identified, the etiology of most cases remains unknown.
- Published
- 2015
- Full Text
- View/download PDF
35. Simulation exercises to strengthen polio outbreak preparedness: experience of the World Health Organization European Region.
- Author
-
Moulsdale HJ, Khetsuriani N, Deshevoi S, Butler R, Simpson J, and Salisbury D
- Subjects
- Europe epidemiology, Humans, World Health Organization, Civil Defense methods, Computer Simulation, Disease Outbreaks, Health Services Research, Poliomyelitis epidemiology, Poliomyelitis prevention & control
- Abstract
Background: Poliovirus importations and related outbreaks continue to occur in polio-free countries, including those in the World Health Organization (WHO) European Region. National preparedness plans for responding to poliovirus introduction are insufficient in many countries of the European Region. We describe a series of polio outbreak simulation exercises that were implemented to formally test polio outbreak preparedness plans in the European Region., Methods: We designed and implemented the exercises, reviewed the results, made recommendations, and assessed the role of outbreak simulation exercises in maintaining regional polio-free status. In addition, we performed a comprehensive review of the national plans of all WHO Member States in the European Region., Results: Three exercises, delivered during 2011-2013 (for the Balkans, United Kingdom, and the Caucasus and Ukraine), revealed that participating countries were generally prepared for poliovirus introduction, but the level of preparedness needed improvement. The areas in particular need of strengthening were national preparedness plans, initial response, plans for securing vaccine supply, and communications., Conclusions: Polio outbreak simulation exercises can be valuable tools to help maintain polio-free status and should be extended to other high-risk countries and subnational areas in the European Region and elsewhere., (© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2014
- Full Text
- View/download PDF
36. Challenges of maintaining polio-free status of the European Region.
- Author
-
Khetsuriani N, Pfeifer D, Deshevoi S, Gavrilin E, Shefer A, Butler R, Jankovic D, Spataru R, Emiroglu N, and Martin R
- Subjects
- Adolescent, Adult, Child, Child, Preschool, Communicable Disease Control economics, Communicable Disease Control methods, Disease Eradication economics, Europe epidemiology, Female, Health Policy, Humans, Infant, Infant, Newborn, International Cooperation, Male, Poliomyelitis transmission, Communicable Disease Control organization & administration, Disease Eradication organization & administration, Disease Outbreaks, Poliomyelitis epidemiology, Poliomyelitis prevention & control
- Abstract
Background: The European region, certified as polio free in 2002, had recent wild poliovirus (WPV) introductions, resulting in a major outbreak in Central Asian countries and Russia in 2010 and in current widespread WPV type 1 circulation in Israel, which endangered the polio-free status of the region., Methods: We assessed the data on the major determinants of poliovirus transmission risk (population immunity, surveillance, and outbreak preparedness) and reviewed current threats and measures implemented in response to recent WPV introductions., Results: Despite high regional vaccination coverage and functioning surveillance, several countries in the region are at high or intermediate risk of poliovirus transmission. Coverage remains suboptimal in some countries, subnational geographic areas, and population groups, and surveillance (acute flaccid paralysis, enterovirus, and environmental) needs further strengthening. Supplementary immunization activities, which were instrumental in the rapid interruption of WPV1 circulation in 2010, should be implemented in high-risk countries to close population immunity gaps. National polio outbreak preparedness plans need strengthening. Immunization efforts to interrupt WPV transmission in Israel should continue., Conclusions: The European region has successfully maintained its polio-free status since 2002, but numerous challenges remain. Staying polio free will require continued coordinated efforts, political commitment and financial support from all countries., (Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US.)
- Published
- 2014
- Full Text
- View/download PDF
37. The role of older children and adults in wild poliovirus transmission.
- Author
-
Blake IM, Martin R, Goel A, Khetsuriani N, Everts J, Wolff C, Wassilak S, Aylward RB, and Grassly NC
- Subjects
- Adolescent, Adult, Age Distribution, Child, Child, Preschool, Congo epidemiology, Disease Outbreaks statistics & numerical data, Geography, Humans, Infant, Infant, Newborn, Models, Biological, Poliomyelitis epidemiology, Tajikistan epidemiology, Poliomyelitis transmission, Poliomyelitis virology, Poliovirus physiology
- Abstract
As polio eradication inches closer, the absence of poliovirus circulation in most of the world and imperfect vaccination coverage are resulting in immunity gaps and polio outbreaks affecting adults. Furthermore, imperfect, waning intestinal immunity among older children and adults permits reinfection and poliovirus shedding, prompting calls to extend the age range of vaccination campaigns even in the absence of cases in these age groups. The success of such a strategy depends on the contribution to poliovirus transmission by older ages, which has not previously been estimated. We fit a mathematical model of poliovirus transmission to time series data from two large outbreaks that affected adults (Tajikistan 2010, Republic of Congo 2010) using maximum-likelihood estimation based on iterated particle-filtering methods. In Tajikistan, the contribution of unvaccinated older children and adults to transmission was minimal despite a significant number of cases in these age groups [reproduction number, R = 0.46 (95% confidence interval, 0.42-0.52) for >5-y-olds compared to 2.18 (2.06-2.45) for 0- to 5-y-olds]. In contrast, in the Republic of Congo, the contribution of older children and adults was significant [R = 1.85 (1.83-4.00)], perhaps reflecting sanitary and socioeconomic variables favoring efficient virus transmission. In neither setting was there evidence for a significant role of imperfect intestinal immunity in the transmission of poliovirus. Bringing the immunization response to the Tajikistan outbreak forward by 2 wk would have prevented an additional 130 cases (21%), highlighting the importance of early outbreak detection and response.
- Published
- 2014
- Full Text
- View/download PDF
38. Seroepidemiology of diphtheria and tetanus among children and young adults in Tajikistan: nationwide population-based survey, 2010.
- Author
-
Khetsuriani N, Zakikhany K, Jabirov S, Saparova N, Ursu P, Wannemuehler K, Wassilak S, Efstratiou A, and Martin R
- Subjects
- Adolescent, Antitoxins blood, Child, Child, Preschool, Enzyme-Linked Immunosorbent Assay, Female, Humans, Immunoglobulin G blood, Infant, Male, Neutralization Tests, Seroepidemiologic Studies, Tajikistan epidemiology, Young Adult, Antibodies, Bacterial blood, Diphtheria epidemiology, Tetanus epidemiology
- Abstract
Background: Tajikistan had a major diphtheria outbreak (≈ 10,000 cases) in the 1990 s, which was controlled after nationwide immunization campaigns with diphtheria-tetanus toxoid in 1995 and 1996. Since 2000, only 52 diphtheria cases have been reported. However, in coverage surveys conducted in 2000 and 2005, diphtheria-tetanus-pertussis vaccine coverage was lower than administratively reported estimates raising concerns about potential immunity gaps. To further assess population immunity to diphtheria in Tajikistan, diphtheria antibody testing was included in a large-scale nationwide serosurvey for vaccine-preventable diseases conducted in connection with a poliomyelitis outbreak in 2010. In addition, the serosurvey provided an opportunity to assess population immunity to tetanus., Methods: Residents of all regions of Tajikistan aged 1-24 years were included in the serosurvey implemented during September-October 2010. Participants were selected through stratified cluster sampling. Specimens were tested for diphtheria antibodies using a Vero cell neutralization assay and for tetanus antibodies using an anti-tetanus IgG ELISA. Antibody concentrations ≥ 0.1 IU/mL were considered seropositive., Results: Overall, 51.4% (95% CI, 47.1%-55.6%) of participants were seropositive for diphtheria and 78.9% (95% CI, 74.7%-82.5%) were seropositive for tetanus. The lowest percentages of seropositivity for both diseases were observed among persons aged 10-19 years: diphtheria seropositivity was 37.1% (95% CI, 31.0%-43.7%) among 10-14 year-olds, and 35.3% (95% CI, 29.9%-41.1%) among 15-19 year-olds; tetanus seropositivity in respective age groups was 65.3% (95% CI, 58.4%-71.6%) and 70.1% (95% CI, 64.5%-75.2%)., Conclusions: Population immunity for diphtheria in Tajikistan is low, particularly among 10-19 year-olds. Population immunity to tetanus is generally higher than for diphtheria, but is suboptimal among 10-19 year-olds. These findings highlight the need to improve routine immunization service delivery, and support a one-time supplementary immunization campaign with diphtheria-tetanus toxoid among birth cohorts aged 1-19 years in 2010 (3-21 years in 2012) to close immunity gaps and prevent diphtheria outbreaks., (Published by Elsevier Ltd.)
- Published
- 2013
- Full Text
- View/download PDF
39. Population immunity to polioviruses in the context of a large-scale wild poliovirus type 1 outbreak in Tajikistan, 2010.
- Author
-
Khetsuriani N, Pallansch MA, Jabirov S, Saparova N, Oberste MS, Wannemuehler K, Ursu P, Wassilak S, and Martin R
- Subjects
- Adolescent, Antibodies, Neutralizing blood, Child, Child, Preschool, Female, Humans, Infant, Male, Seroepidemiologic Studies, Tajikistan epidemiology, Young Adult, Antibodies, Viral blood, Disease Outbreaks, Poliomyelitis epidemiology, Poliomyelitis prevention & control, Poliovirus immunology
- Abstract
Background: A serosurvey to evaluate population immunity to polioviruses (PVs) in the context of the importation-related wild PV1 outbreak in Tajikistan in 2010 (461 confirmed cases among children and young adults) was conducted., Methods: Serum specimens from a nationwide sample of 1-24 year-old persons selected through stratified cluster sampling (n=2447) were tested for neutralizing antibodies to all three PV types. Samples with titers<1:8 were considered seronegative. The serosurvey was conducted during the interval after mOPV1 supplementary immunization activities (SIAs) and before tOPV SIAs (targeting ages ≤ 15 years) implemented to control the outbreak. In the absence of pre-outbreak specimens, results for PV3 were used as a proxy for pre-outbreak PV1 immunity patterns., Results: Overall, PV1 seroprevalence was 98.9%, PV2 seroprevalence was 98.8%, and PV3 seroprevalence was 86.9%. PV1 and PV2 seroprevalence exceeded 95% in all age groups and regions. PV3 seroprevalence was <90% in all age groups and regions, except 15-19 year-olds (91.7%) and Dushanbe (90.0%). PV3 seroprevalence was lowest among 1-4 (82.7%) and 5-9 (84.4%) year-olds, particularly among 1-4 year-olds in Kurgan-Tube (76.3%) and RRS (80.0%) regions. Birth cohorts immunized only through routine services (ages, 1-7 years) had lower PV3 seroprevalence than birth cohorts targeted by the SIAs during 1995-2002 (8-19 years): 82.5% versus 89.3%, p<0.001., Conclusions: Suboptimal (<90%) PV3 seroprevalence across wide age range suggests the outbreak resulted from accumulation of susceptibles due to suboptimal coverage over a long time period, particularly in the birth cohorts immunized only through routine services and in areas where the outbreak began (Kurgan-Tube and RRS). High PV1 seroprevalence indicates that mOPV1 SIAs with expanded target age (≤ 15 years) succeeded in closing the immunity gap and ongoing WPV1 transmission is unlikely. To accelerate outbreak control in areas which have been polio-free for long time, expanding SIA target age should be considered., (Copyright © 2013. Published by Elsevier Ltd.)
- Published
- 2013
- Full Text
- View/download PDF
40. Diversity of picornaviruses in rural Bolivia.
- Author
-
Nix WA, Khetsuriani N, Peñaranda S, Maher K, Venczel L, Cselkó Z, Freire MC, Cisterna D, Lema CL, Rosales P, Rodriguez JR, Rodriguez W, Halkyer P, Ronveaux O, Pallansch MA, and Oberste MS
- Subjects
- Adolescent, Animals, Bolivia epidemiology, Child, Child, Preschool, Feces virology, Female, Humans, Infant, Male, Molecular Epidemiology, Molecular Sequence Data, Paraplegia epidemiology, Paraplegia virology, Picornaviridae isolation & purification, Picornaviridae Infections veterinary, Real-Time Polymerase Chain Reaction, Reverse Transcriptase Polymerase Chain Reaction, Rural Population, Sequence Analysis, DNA, Swine, Swine Diseases epidemiology, Swine Diseases virology, Young Adult, Picornaviridae classification, Picornaviridae genetics, Picornaviridae Infections epidemiology, Picornaviridae Infections virology
- Abstract
The family Picornaviridae is a large and diverse group of viruses that infect humans and animals. Picornaviruses are among the most common infections of humans and cause a wide spectrum of acute human disease. This study began as an investigation of acute flaccid paralysis (AFP) in a small area of eastern Bolivia, where surveillance had identified a persistently high AFP rate in children. Stools were collected and diagnostic studies ruled out poliovirus. We tested stool specimens from 51 AFP cases and 34 healthy household or community contacts collected during 2002-2003 using real-time and semi-nested reverse transcription polymerase chain reaction assays for enterovirus, parechovirus, cardiovirus, kobuvirus, salivirus and cosavirus. Anecdotal reports suggested a temporal association with neurological disease in domestic pigs, so six porcine stools were also collected and tested with the same set of assays, with the addition of an assay for porcine teschovirus. A total of 126 picornaviruses were detected in 73 of 85 human individuals, consisting of 53 different picornavirus types encompassing five genera (all except Kobuvirus). All six porcine stools contained porcine and/or human picornaviruses. No single virus, or combination of viruses, specifically correlated with AFP; however, the study revealed a surprising complexity of enteric picornaviruses in a single community.
- Published
- 2013
- Full Text
- View/download PDF
41. World Health Organization regional assessments of the risks of poliovirus outbreaks.
- Author
-
Lowther SA, Roesel S, O'Connor P, Landaverde M, Oblapenko G, Deshevoi S, Ajay G, Buff A, Safwat H, Salla M, Tangermann R, Khetsuriani N, Martin R, and Wassilak S
- Subjects
- Humans, Poliomyelitis prevention & control, Risk Assessment, Disease Outbreaks, Poliomyelitis epidemiology, World Health Organization
- Abstract
While global polio eradication requires tremendous efforts in countries where wild polioviruses (WPVs) circulate, numerous outbreaks have occurred following WPV importation into previously polio-free countries. Countries that have interrupted endemic WPV transmission should continue to conduct routine risk assessments and implement mitigation activities to maintain their polio-free status as long as wild poliovirus circulates anywhere in the world. This article reviews the methods used by World Health Organization (WHO) regional offices to qualitatively assess risk of WPV outbreaks following an importation. We describe the strengths and weaknesses of various risk assessment approaches, and opportunities to harmonize approaches. These qualitative assessments broadly categorize risk as high, medium, or low using available national information related to susceptibility, the ability to rapidly detect WPV, and other population or program factors that influence transmission, which the regions characterize using polio vaccination coverage, surveillance data, and other indicators (e.g., sanitation), respectively. Data quality and adequacy represent a challenge in all regions. WHO regions differ with respect to the methods, processes, cut-off values, and weighting used, which limits comparisons of risk assessment results among regions. Ongoing evaluation of indicators within regions and further harmonization of methods between regions are needed to effectively plan risk mitigation activities in a setting of finite resources for funding and continued WPV circulation., (© 2013 Society for Risk Analysis.)
- Published
- 2013
- Full Text
- View/download PDF
42. Molecular genotyping and epidemiology of measles virus transmission in the World Health Organization European Region, 2007-2009.
- Author
-
Mankertz A, Mulders MN, Shulga S, Kremer JR, Brown KE, Santibanez S, Muller CP, Tikhonova N, Lipskaya G, Jankovic D, Khetsuriani N, Martin R, and Gavrilin E
- Subjects
- Europe epidemiology, Genotype, Humans, Measles transmission, Measles virus classification, Molecular Epidemiology, Phylogeny, Population Surveillance, Measles epidemiology, Measles virology, Measles virus genetics, World Health Organization organization & administration
- Abstract
Background: In 2002, the World Health Organization (WHO) adopted a goal to eliminate measles in the European Region by 2010. Measles elimination is defined as the interruption of indigenous measles virus (MV) transmission. The molecular epidemiology of MV transmission in the WHO European Region was studied through the investigation of reported cases and outbreaks to monitor the region's progress toward its measles elimination goal., Methods: National and regional laboratories performed molecular characterization of MV detected between 2007 and 2009 in the WHO European Region. To document indigenous transmission and importations into the region, we analyzed genotyping results and epidemiological data on measles outbreaks reported by the member states., Results: Since 2007, MV genotype D6 has not been reported in the WHO European Region, suggesting that its chains of transmission have been interrupted, whereas several other MV genotypes are still circulating. Although several European countries have already interrupted indigenous MV transmission, genotyping showed that 3 endemic MV transmission chains have been reestablished in other countries., Conclusions: The WHO European Region 2010 goal will not be met, as indigenous transmission of MV has not been interrupted. As the region begins to document its process of elimination verification to monitor progress toward the goal, countries will need to ensure that genotyping is performed in all measles outbreaks., (© The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
43. Supplementary immunization activities to achieve measles elimination: experience of the European Region.
- Author
-
Khetsuriani N, Deshevoi S, Goel A, Spika J, Martin R, and Emiroglu N
- Subjects
- Adolescent, Adult, Child, Child, Preschool, Europe epidemiology, Female, Humans, Incidence, Infant, Male, Measles-Mumps-Rubella Vaccine administration & dosage, Population Surveillance, Retrospective Studies, Time Factors, Young Adult, Immunization Programs, Measles epidemiology, Measles prevention & control, Measles Vaccine administration & dosage
- Abstract
Background: Supplementary immunization activities (SIAs) using measles-containing vaccine (MCV) have had a substantial impact on reducing mortality associated with measles worldwide., Methods: To assess impact of SIAs on measles incidence in the World Health Organization European Region and their role at the final stages of measles elimination efforts in Europe, we reviewed information on SIAs, measles surveillance, and routine vaccination coverage during 2000-2009., Results: During 2000-2009, >57 million persons received MCV through SIAs in 16 countries. The Region primarily focused on catch-up campaigns with wider target age groups than in other regions and subsequently relied on routine vaccination rather than periodic follow-up SIAs for the second MCV dose. In addition, the concept of SIAs has been expanded from short-term (<30 days) mass campaigns implemented in other regions to incorporate vaccination efforts over longer periods and outbreak response vaccination. In 2009, 14 of 16 countries that conducted SIAs reported no measles cases or <1 case per 1,000,000 population, reflecting the post-SIA decrease in incidence., Conclusions: SIAs have made a substantial contribution to the success of measles elimination efforts and will likely remain an important strategy for interrupting measles virus transmission in the European Region, although specific approaches will vary by country., (Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2011.)
- Published
- 2011
- Full Text
- View/download PDF
44. Status of rubella and congenital rubella syndrome surveillance, 2005-2009, the World Health Organization European Region.
- Author
-
Zimmerman LA, Muscat M, Jankovic D, Goel A, Bang H, Khetsuriani N, and Martin R
- Subjects
- Europe epidemiology, Humans, Time Factors, Population Surveillance, Rubella epidemiology, Rubella Syndrome, Congenital epidemiology, World Health Organization
- Abstract
Background: The World Health Organization European Region has a goal for rubella elimination and congenital rubella syndrome (CRS) prevention. Although all Member States recommend a rubella-containing vaccine in their national immunization programs, rubella and CRS continue to occur, and surveillance quality varies throughout the region., Methods: To describe the status of regional rubella and CRS surveillance and assess progress toward elimination, we reviewed surveillance practices by surveying all 53 Member States and analyzed rubella and CRS surveillance data during 2005-2009., Results: Overall, 41 (91%) of 45 responding Member States have nationwide rubella surveillance, and 39 (87%) have nationwide CRS surveillance. During 2005-2009, rubella cases reported in the region decreased by 94% from 206,359 cases to 11,623 cases. The greatest decrease (99%) was observed in newly independent states of the former Soviet Union. In the rest of the region, high rubella incidence was observed in Poland, Romania, Italy, and San Marino during 2005-2008 and in Poland, Bosnia and Herzegovina, and Austria in 2009. A total of 68 CRS cases were reported during 2005-2009., Conclusions: As the foundation to achieving and verifying rubella elimination, high-quality rubella and CRS surveillance needs to be implemented and sustained in all Member States., (Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2011.)
- Published
- 2011
- Full Text
- View/download PDF
45. Japanese encephalitis virus remains an important cause of encephalitis in Thailand.
- Author
-
Olsen SJ, Supawat K, Campbell AP, Anantapreecha S, Liamsuwan S, Tunlayadechanont S, Visudtibhan A, Lupthikulthum S, Dhiravibulya K, Viriyavejakul A, Vasiknanonte P, Rajborirug K, Watanaveeradej V, Nabangchang C, Laven J, Kosoy O, Panella A, Ellis C, Henchaichon S, Khetsuriani N, Powers AM, Dowell SF, and Fischer M
- Subjects
- Adolescent, Adult, Child, Child, Preschool, Encephalitis Virus, Japanese immunology, Encephalitis, Japanese prevention & control, Encephalitis, Japanese virology, Humans, Infant, Japanese Encephalitis Vaccines therapeutic use, Middle Aged, Thailand epidemiology, Young Adult, Encephalitis Virus, Japanese isolation & purification, Encephalitis, Japanese epidemiology
- Abstract
Background: Japanese encephalitis virus (JEV) is endemic in Thailand and prevention strategies include vaccination, vector control, and health education., Methods: Between July 2003 and August 2005, we conducted hospital-based surveillance for encephalitis at seven hospitals in Bangkok and Hat Yai. Serum and cerebrospinal (CSF) specimens were tested for evidence of recent JEV infection by immunoglobulin M (IgM) enzyme-linked immunosorbent assay (ELISA) and a plaque reduction neutralization test (PRNT)., Results: Of the 147 patients enrolled and tested, 24 (16%) had evidence of acute flavivirus infection: 22 (15%) with JEV and two (1%) with dengue virus. Of the 22 Japanese encephalitis (JE) cases, 10 (46%) were aged ≤ 15 years. The median length of hospital stay was 13 days; one 13-year-old child died. Ten percent of encephalitis patients enrolled in Bangkok hospitals were found to have JEV infection compared to 28% of patients enrolled in hospitals in southern Thailand (p < 0.01). Four (40%) of the 10 children with JE were reported as being vaccinated., Conclusions: JEV remains an important cause of encephalitis among hospitalized patients in Thailand. The high proportion of JE among encephalitis cases is concerning and additional public health prevention efforts or expanded vaccination may be needed., (Published by Elsevier Ltd.)
- Published
- 2010
- Full Text
- View/download PDF
46. Outbreak of life-threatening coxsackievirus B1 myocarditis in neonates.
- Author
-
Verma NA, Zheng XT, Harris MU, Cadichon SB, Melin-Aldana H, Khetsuriani N, Oberste MS, and Shulman ST
- Subjects
- Chicago epidemiology, Cluster Analysis, Coxsackievirus Infections mortality, Coxsackievirus Infections pathology, Enterovirus B, Human isolation & purification, Enterovirus B, Human pathogenicity, Female, Humans, Infant, Newborn, Male, Myocarditis mortality, Myocarditis pathology, Serotyping, Coxsackievirus Infections epidemiology, Disease Outbreaks, Enterovirus B, Human classification, Myocarditis epidemiology, Myocarditis virology
- Abstract
In the summer and fall of 2007, we observed a unique cluster of cases of severe coxsackievirus B1 (CVB1) infection among Chicago area neonates. Eight neonates had closely related strains of CVB1 that were typed at the Centers of Disease Control and Prevention; 2 other neonates had CVB infections, 1 of which was further identified as serotype CVB1. All had severe myocarditis; 1 neonate underwent heart transplantation, and 1 died of severe left ventricular dysfunction.
- Published
- 2009
- Full Text
- View/download PDF
47. Increased activity of Coxsackievirus B1 strains associated with severe disease among young infants in the United States, 2007-2008.
- Author
-
Wikswo ME, Khetsuriani N, Fowlkes AL, Zheng X, Peñaranda S, Verma N, Shulman ST, Sircar K, Robinson CC, Schmidt T, Schnurr D, and Oberste MS
- Subjects
- Centers for Disease Control and Prevention, U.S., Cluster Analysis, Coxsackievirus Infections mortality, Coxsackievirus Infections pathology, Humans, Infant, Newborn, Phylogeny, Sentinel Surveillance, Serotyping, United States epidemiology, Coxsackievirus Infections epidemiology, Coxsackievirus Infections virology, Enterovirus B, Human classification, Enterovirus B, Human genetics, Enterovirus B, Human isolation & purification
- Abstract
Background: Enterovirus infections are very common and typically cause mild illness, although neonates are at higher risk for severe illness. In 2007, the Centers for Disease Control and Prevention (CDC) received multiple reports of severe neonatal illness and death associated with coxsackievirus B1 (CVB1), a less common enterovirus serotype not previously associated with death in surveillance reports to the CDC., Methods: This report includes clinical, epidemiologic, and virologic data from cases of severe neonatal illness associated with CVB1 reported during the period from 2007 through 2008 to the National Enterovirus Surveillance System (NESS), a voluntary, passive surveillance system. Also included are data on additional cases reported to the CDC outside of the NESS. Virus isolates or original specimens obtained from patients from 25 states were referred to the CDC picornavirus laboratory for molecular typing or characterization., Results: During 2007-2008, the NESS received 1079 reports of enterovirus infection. CVB1 accounted for 176 (23%) of 775 reported cases with known serotype, making it the most commonly reported serotype for the first time ever in the NESS. Six neonatal deaths due to CVB1 infection were also reported to the CDC during that time. Phylogenetic analysis of the 2007 and 2008 CVB1 strains indicated that the increase in cases resulted from widespread circulation of a single genetic lineage that had been present in the United States since at least 2001., Conclusions: Healthcare providers and public health departments should be vigilant to the possibility of continuing CVB1-associated neonatal illness, and testing and continued reporting of enterovirus infections should be encouraged.
- Published
- 2009
- Full Text
- View/download PDF
48. Limited duration of vaccine poliovirus and other enterovirus excretion among human immunodeficiency virus infected children in Kenya.
- Author
-
Khetsuriani N, Helfand R, Pallansch M, Kew O, Fowlkes A, Oberste MS, Tukei P, Muli J, Makokha E, and Gary H
- Subjects
- Child, Preschool, Enterovirus classification, Enterovirus genetics, Enterovirus Infections transmission, Humans, Kenya, Poliomyelitis transmission, Poliovirus classification, Poliovirus genetics, Enterovirus isolation & purification, Feces virology, HIV Infections virology, Poliovirus isolation & purification, Poliovirus Vaccines administration & dosage, Virus Shedding
- Abstract
Background: Immunodeficient persons with persistent vaccine-related poliovirus infection may serve as a potential reservoir for reintroduction of polioviruses after wild poliovirus eradication, posing a risk of their further circulation in inadequately immunized populations., Methods: To estimate the potential for vaccine-related poliovirus persistence among HIV-infected persons, we studied poliovirus excretion following vaccination among children at an orphanage in Kenya. For 12 months after national immunization days, we collected serial stool specimens from orphanage residents aged <5 years at enrollment and recorded their HIV status and demographic, clinical, immunological, and immunization data. To detect and characterize isolated polioviruses and non-polio enteroviruses (NPEV), we used viral culture, typing and intratypic differentiation of isolates by PCR, ELISA, and nucleic acid sequencing. Long-term persistence was defined as shedding for >or= 6 months., Results: Twenty-four children (15 HIV-infected, 9 HIV-uninfected) were enrolled, and 255 specimens (170 from HIV-infected, 85 from HIV-uninfected) were collected. All HIV-infected children had mildly or moderately symptomatic HIV-disease and moderate-to-severe immunosuppression. Fifteen participants shed vaccine-related polioviruses, and 22 shed NPEV at some point during the study period. Of 46 poliovirus-positive specimens, 31 were from HIV-infected, and 15 from HIV-uninfected children. No participant shed polioviruses for >or= 6 months. Genomic sequencing of poliovirus isolates did not reveal any genetic evidence of long-term shedding. There was no long-term shedding of NPEV., Conclusion: The results indicate that mildly to moderately symptomatic HIV-infected children retain the ability to clear enteroviruses, including vaccine-related poliovirus. Larger studies are needed to confirm and generalize these findings.
- Published
- 2009
- Full Text
- View/download PDF
49. Systemic infection with enteric adenovirus in immunocompetent child with Haemophilus influenzae disease.
- Author
-
Khetsuriani N, Tong S, Lu X, Reed S, Erdman D, Campbell A, Supawat K, Liamsuwan S, Jothikumar N, and Olsen S
- Subjects
- Adenoviruses, Human classification, Adenoviruses, Human genetics, Enteritis virology, Haemophilus Infections microbiology, Humans, Infant, Male, Polymerase Chain Reaction, Sequence Analysis, DNA, Thailand, Adenovirus Infections, Human blood, Adenovirus Infections, Human cerebrospinal fluid, Adenovirus Infections, Human complications, Adenovirus Infections, Human virology, Adenoviruses, Human isolation & purification, Encephalitis, Viral blood, Encephalitis, Viral cerebrospinal fluid, Encephalitis, Viral complications, Encephalitis, Viral virology, Haemophilus Infections complications, Haemophilus influenzae isolation & purification, Immunocompetence
- Published
- 2009
- Full Text
- View/download PDF
50. Ongoing measles and rubella transmission in Georgia, 2004-05: implications for the national and regional elimination efforts.
- Author
-
Doshi S, Khetsuriani N, Zakhashvili K, Baidoshvili L, Imnadze P, and Uzicanin A
- Subjects
- Adolescent, Adult, Antibodies, Viral blood, Child, Child, Preschool, Disease Outbreaks, Female, Georgia (Republic) epidemiology, Humans, Immunization Programs statistics & numerical data, Immunization Schedule, Immunoglobulin M blood, Incidence, Infant, Infant, Newborn, Male, Measles prevention & control, Measles transmission, Measles virus immunology, Measles-Mumps-Rubella Vaccine administration & dosage, Population Surveillance, Rubella prevention & control, Rubella transmission, Rubella virus immunology, Seasons, Vaccination statistics & numerical data, Young Adult, Measles epidemiology, Rubella epidemiology
- Abstract
Background: In 2004-05, Georgia experienced large-scale concurrent measles and rubella outbreaks. We analysed measles and rubella epidemiology in Georgia to describe disease trends, determine the cause of the outbreaks, identify challenges to achieving disease elimination goals and propose interventions to overcome them., Methods: We reviewed national measles and rubella surveillance and vaccination coverage data, focusing on the 2004-05 outbreaks, and conducted a measles vaccine effectiveness (VE) study using data from a 2004 school-based outbreak., Results: Before 2004, the last large measles outbreak after measles vaccination was introduced (in 1966) in Georgia, was in 1988 (incidence rate, 36/100 000); the highest year for rubella was 1985 (110/100 000). During 2004-05, 8391 measles cases and 5151 rubella cases were reported (most of them diagnosed clinically). Of 358 suspected measles cases tested, 181 (51%) were positive for measles-IgM antibody; of 240 suspected rubella cases tested, 50 (21%) were positive for rubella-IgM antibody. Over 90% of measles cases were in persons born after 1979; 90% of rubella cases were in persons born after 1987. Approximately 41% of measles cases and 88% of rubella cases were unvaccinated. Estimated measles VE (>/=1 vs 0 doses) was 86% (95% CI, 58-96%)., Conclusions: The outbreak likely resulted from failure to vaccinate rather than vaccine failure. Susceptible persons likely accumulated due to the long absence of large outbreaks and decreased coverage after the collapse of Soviet Union. To interrupt measles and rubella transmission in Georgia and achieve disease elimination goals by 2010, supplementary immunization activities should target children and young adults.
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.